Educational ActivitiesSUPPORT-ProNCT04859205
The SUPPORT-Pro Online Platform for Healthcare Professionals Treating Individuals Living With T1D
A study testing Intervention in people with Educational Activities, run by McGill University at 1 site in Canada.
Trial summary
Health care professionals (HCPs) help an support patients living with type 1 diabetes (PWT1D) who need to achieve optimal blood glucose control in order to prevent short and long term complications of T1D. However, studies show that not all HCPs are aware of T1D management as most of them only see PWT1D occasionally. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Educational Activities
- What is being tested?
- Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 229 participants
- Where
- 1 siteCanada
- Study dates
- 13 May 2021to 20 Feb 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Certified Health Care Professional (nurse, physician (including resident in medicine), dietitian, pharmacist) who is member of a regulatory body in Canada
- Self-reported working with at least 1 patient with type 1 diabetes in the last six months
- Has access to the Internet
- Use of an active email address
- Comprehension of English or French
Who cannot join
- Certified diabetes educators
- Working in a T1D specialized clinic
- Living with T1D
- Currently living with someone with T1D (e.g. kid, partner, etc.)
- Working in the pharmaceutical industry
Trial locations and contacts
1 site in 1 country.
Canada1 site
Institut de Recherches Cliniques de Montréal
Montreal, Quebec, H2W 1R7
About this study
Official title: The SUPPORT-Pro Online Platform: Helping Healthcare Professionals to Increase Their Confidence Levels in Treating Individuals Living With T1D
Health care professionals (HCPs) help an support patients living with type 1 diabetes (PWT1D) who need to achieve optimal blood glucose control in order to prevent short and long term complications of T1D. However, studies show that not all HCPs are aware of T1D management as most of them only see PWT1D occasionally. This makes it difficult for HCPs to remain aware of the particularities of the condition and stay up-to-date on rapidly evolving technologies and therapies available. Moreover, low confidence levels and the inaccessibility to continuing medical education on the specificities of new therapies and technologies might increase the failure of HCPs to propose the optimal treatment plan to their PWT1D.
The SUPPORT online platform, that was first developed for PWT1D, was adjusted to suit the needs of HCPs (SUPPORT-Pro). The regularly updated bilingual (English and French) peer-reviewed content of SUPPORT, which covers the various elements that an individual with T1D needs to know to manage the disease and aims at making a better use of technologies and new therapies, is the first in its kind and is highly relevant for HCPs.
The main objective of this study is to determine if the SUPPORT-Pro online training platform can increase HCPs' (dietitians, nurses, pharmacists, medical doctors) confidence level in treating individuals with T1D. This study is a non-randomized pre-post trial. We hypothesize that the training provided through the SUPPORT-Pro online platform will significantly increase HCPs' confidence level in treating individuals with T1D after 3 months when compared to their confidence level before the intervention.
- Conditions
- Educational Activities
- Being tested
- Intervention
- Keywords
- Type 1 diabetes
- Medical subject headings
- Diabetes Mellitus, Type 1
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
InterventionBehavioural
Participants will have access to the SUPPORT-Pro self-guided online training platform addressing many aspects of type 1 diabetes care. The SUPPORT-Pro content was developped by a team of health professionals specialized in type 1 diabetes as well as patient partners. It's content is regularly updated, evidence-based and divided into 6 categories (medication, blood glucose monitoring, diet, physical activity, hypo and hyperglycemia, health and other particularities). In each category, users can pick between 3 levels (beginner, intermediate and advanced) according to their level of confidence and knowledge.
Participants will be asked to fill out questionnaires at baseline, 3-month, and 12-month of the intervention which include the following: Eligibility assessment, identification, background, confidence, platform satisfaction.
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | All participants partaking the SUPPORT-Pro study will receive the full intervention for 3 months which implies: (1) Full access to the platform (2) a newsletter sent by email every 2 weeks to inform them on the new blogs posted on the platform.
During the following 9 months, participants will still have access to the platform, but no newsletter will be sent (sustainability phase). Receives: Behavioral: Intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
To compare the level of confidence in treating individuals with type 1 diabetes measured at 3 months to the level of confidence measured at baseline.
Levels of confidence will be measured using a questionnaire inspired from the Maternal Self-Efficacy for Diabetes Management Scale (MSED). For this study, MSED was modified to better assess the self-confidence of health care professionals. We have converted the 17-item questionnaire to a 19-item questionnaire (removing questions specific to familial support and adding questions on new therapies and technologies) and edited the wording of the questions. Every item is rated on a scale from 1 to 5. The satisfaction score will be the sum of all items, on a maximum of 95.
Confidence levels at 3 months and at baseline will be compared using paired t-test with a 95% confidence interval, if normality assumption of the paired difference holds. Otherwise, the non-parametric counterpart, Wilcoxon signed-rank test, will be used and a 95% non-parametric confidence interval will be provided.
Measured: 3 months
Secondary outcomes (8)
To compare, in each specific group of HCPs (nurses, dietitians, doctors and pharmacists), the confidence levels in treating their patients with T1D after 3 months of access to the SUPPORT-Pro platform with confidence at baseline.
Levels of confidence will be measured using a questionnaire inspired from the Maternal Self-Efficacy for Diabetes Management Scale (MSED). For this study, MSED was modified to better assess the self-confidence of health care professionals. We have converted the 17-item questionnaire to a 19-item questionnaire (removing questions specific to familial support and adding questions on new therapies and technologies) and edited the wording of the questions. Every item is rated on a scale from 1 to 5. The satisfaction score will be the sum of all items, on a maximum of 95.
Confidence levels at 3 months and at baseline will be compared using paired t-test with a 95% confidence interval, if normality assumption of the paired difference holds. Otherwise, the non-parametric counterpart, Wilcoxon signed-rank test, will be used and a 95% non-parametric confidence interval will be provided.
Measured: 3 months
To measure the sustainability of change in all HCPs' confidence in treating patients with T1D at 12 months
Levels of confidence will be measured at baseline, after 3 months and after 12 months using a questionnaire inspired from the Maternal Self-Efficacy for Diabetes Management Scale (MSED). For this study, MSED was modified to better assess the self-confidence of health care professionals. We have converted the 17-item questionnaire to a 19-item questionnaire (removing questions specific to familial support and adding questions on new therapies and technologies) and edited the wording of the questions. Every item is rated on a scale from 1 to 5. The satisfaction score will be the sum of all items, on a maximum of 95.
Sustainability of change will be assessed by comparing level of confidence at the 3 time points using a one-way repeated measures ANCOVA, with change from baseline as the outcome, and baseline level of confidence adjusted for in the model.
Measured: 12 months
Time spent on the platform
Using back-end data collected from Google Analytics, the total time (in minutes) spent on the platform during 3 months will be presented using mean and SD (standard errors) or median and interquartile intervals, depending on its normality.
Measured: 3 months
Number of posts of the discussion forum
Using back-end data collected from Google Analytics, the number of posts on the discussion forum forum will be presented using mean and SD (standard errors) or median and interquartile intervals, depending on its normality.
Measured: 3 months
Number of completed courses
Using back-end data collected from Google Analytics, the number of completed courses will be presented using mean and SD (standard errors) or median and interquartile intervals, depending on its normality.
Measured: 3 months
Number of completed categories
Using back-end data collected from Google Analytics, the number completed category (maximum of 6) will be presented using mean and SD (standard errors) or median and interquartile intervals, depending on its normality.
Measured: 3 months
Number of viewed videos
Using back-end data collected from Google Analytics, the number of viewed videos will be presented using mean and SD (standard errors) or median and interquartile intervals, depending on its normality.
Measured: 3 months
Satisfaction of the platform.
After using the platform for 3 months, participants will be invited to complete a satisfaction questionnaire which includes open ended questions and a 7-items Likert scale (from 1 to 7, total score on 49).
Continuous endpoints will be presented using mean and SD (standard errors) or median and interquartile intervals, depending on their normality. Categorical variables will be presented using frequencies and percentages.
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Apr 2021
- Study start13 May 2021
- Primary completion20 Dec 2022
- Study completion20 Feb 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Educational ActivitiesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- This study is a non-randomized pre-post trial.
- Masking
- None (open label)
- Enrolment
- 229 participants (actual)
Sponsor and investigators
- Lead sponsor
- McGill University
- Sponsor type
- University, hospital or other
- Collaborators
- Institut de Recherches Cliniques de Montreal
- Responsible party
- Principal investigator, Anne-Sophie Brazeau, McGill University
- Investigators
- Anne-Sophie Brazeau, PhD, Principal investigator, McGill University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04859205
- Sponsor's protocol ID
- 2021-1107
- Acronym
- SUPPORT-Pro
- Status last verified
- Sep 2025
- First submitted
- 12 Apr 2021
- Last updated
- 25 Sep 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The SUPPORT-Pro Online Platform: Helping Healthcare Professionals to Increase Their Confidence Levels in Treating Individuals Living With T1D
- ClinicalTrials.gov ID
- NCT04859205
- Acronym / sponsor ID
- SUPPORT-Pro / 2021-1107
- Conditions
- Educational Activities
- Keywords
- Type 1 diabetes
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 229 participants (actual)
- Lead sponsor
- McGill UniversityUniversity, hospital or other
- Collaborators
- Institut de Recherches Cliniques de Montreal
- Study start
- 13 May 2021 (actual)
- Primary completion
- 20 Dec 2022 (actual)
- Study completion
- 20 Feb 2023 (actual)
- First posted
- 26 Apr 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Health care professionals (HCPs) help an support patients living with type 1 diabetes (PWT1D) who need to achieve optimal blood glucose control in order to prevent short and long term complications of T1D. However, studies show that not all HCPs are aware of T1D management as most of them only see PWT1D occasionally. This makes it difficult for HCPs to remain aware of the particularities of the condition and stay up-to-date on rapidly evolving technologies and therapies available. Moreover, low confidence levels and the inaccessibility to continuing medical education on the specificities of new therapies and technologies might increase the failure of HCPs to propose the optimal treatment plan to their PWT1D.
The SUPPORT online platform, that was first developed for PWT1D, was adjusted to suit the needs of HCPs (SUPPORT-Pro). The regularly updated bilingual (English and French) peer-reviewed content of SUPPORT, which covers the various elements that an individual with T1D needs to know to manage the disease and aims at making a better use of technologies and new therapies, is the first in its kind and is highly relevant for HCPs.
The main objective of this study is to determine if the SUPPORT-Pro online training platform can increase HCPs' (dietitians, nurses, pharmacists, medical doctors) confidence level in treating individuals with T1D. This study is a non-randomized pre-post trial. We hypothesize that the training provided through the SUPPORT-Pro online platform will significantly increase HCPs' confidence level in treating individuals with T1D after 3 months when compared to their confidence level before the intervention.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- This study is a non-randomized pre-post trial.
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Behavioral: InterventionAll participants partaking the SUPPORT-Pro study will receive the full intervention for 3 months which implies: (1) Full access to the platform (2) a newsletter sent by email every 2 weeks to inform them on the new blogs posted on the platform. During the following 9 months, participants will still have access to the platform, but no newsletter will be sent (sustainability phase). |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Certified Health Care Professional (nurse, physician (including resident in medicine), dietitian, pharmacist) who is member of a regulatory body in Canada
- Self-reported working with at least 1 patient with type 1 diabetes in the last six months
- Has access to the Internet
- Use of an active email address
- Comprehension of English or French
Key exclusion criteria (5 listed)
- Certified diabetes educators
- Working in a T1D specialized clinic
- Living with T1D
- Currently living with someone with T1D (e.g. kid, partner, etc.)
- Working in the pharmaceutical industry
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| InterventionParticipants will have access to the SUPPORT-Pro self-guided online training platform addressing many aspects of type 1 diabetes care. The SUPPORT-Pro content was developped by a team of health professionals specialized in type 1 diabetes as well as patient partners. It's content is regularly updated, evidence-based and divided into 6 categories (medication, blood glucose monitoring, diet, physical activity, hypo and hyperglycemia, health and other particularities). In each category, users can pick between 3 levels (beginner, intermediate and advanced) according to their level of confidence and knowledge. Participants will be asked to fill out questionnaires at baseline, 3-month, and 12-month of the intervention which include the following: Eligibility assessment, identification, background, confidence, platform satisfaction. | Behavioural | Intervention |
Primary outcome
To compare the level of confidence in treating individuals with type 1 diabetes measured at 3 months to the level of confidence measured at baseline.
Time frame: 3 months
Levels of confidence will be measured using a questionnaire inspired from the Maternal Self-Efficacy for Diabetes Management Scale (MSED). For this study, MSED was modified to better assess the self-confidence of health care professionals. We have converted the 17-item questionnaire to a 19-item questionnaire (removing questions specific to familial support and adding questions on new therapies and technologies) and edited the wording of the questions. Every item is rated on a scale from 1 to 5. The satisfaction score will be the sum of all items, on a maximum of 95. Confidence levels at 3 months and at baseline will be compared using paired t-test with a 95% confidence interval, if normality assumption of the paired difference holds. Otherwise, the non-parametric counterpart, Wilcoxon signed-rank test, will be used and a 95% non-parametric confidence interval will be provided.
8 secondary outcomes
To compare, in each specific group of HCPs (nurses, dietitians, doctors and pharmacists), the confidence levels in treating their patients with T1D after 3 months of access to the SUPPORT-Pro platform with confidence at baseline.
Time frame: 3 months
To measure the sustainability of change in all HCPs' confidence in treating patients with T1D at 12 months
Time frame: 12 months
Time spent on the platform
Time frame: 3 months
Number of posts of the discussion forum
Time frame: 3 months
Number of completed courses
Time frame: 3 months
Number of completed categories
Time frame: 3 months
Number of viewed videos
Time frame: 3 months
Satisfaction of the platform.
Time frame: 3 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Sep 2025.
- Individual participant dataSharing planned: No
Related trials for Educational Activities
Enrolling by invitation
Impact of a Playful Family Education Strategy With ICT on Childhood Obesity Prevention
Pediatric Obesity, Childhood Obesity
Not yet recruiting
Gamified Versus Regular Exercise Snacks on Stationary Bikes, as One 10-Minute or Two 5-Minute Sessions a Day, for Children in an Inclusive Primary School
Exercise, Sedentary Behavior
Active, not recruiting
Physical Activity Education and Quality of Life Study in Breast Cancer Chemotherapy Patients
Breast Cancer
Not yet recruiting
Active Airways for Children and Young People With Asthma
Asthma Childhood, Exercise
Active, not recruiting
Nursing Students' Brain/MS Immersive Three-Dimensional Learning Activity
Multiple Sclerosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anne-Sophie Brazeau, PhD principal investigator
McGill University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Intervention in people with Educational Activities, run by McGill University at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To compare the level of confidence in treating individuals with type 1 diabetes measured at 3 months to the level of confidence measured at baseline. (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2025.